Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Joerg Herrmann

Showing results (201-210 of 269) with videos related to

Pageof 27
Sort By:
The Oncologist|August 10, 2022
Factors Associated With Physical Activity Levels in Patients With Breast CancerPaulina S Marell, Robert A Vierkant, Janet E Olson, et al.
International Journal of Cardiology|June 10, 2016
Relation between fractional flow reserve value of coronary lesions with deferred revascularization and cardiovascular outcomes in non-diabetic and diabetic patientsZhi Liu, Yasushi Matsuzawa, Joerg Herrmann, et al.
Cell Metabolism|June 17, 2025
Itaconate promotes inflammatory responses in tissue-resident alveolar macrophages and exacerbates acute lung injuryMengtian Shan, Song Zhang, Zhibing Luo, et al.
Biomedicines|May 4, 2026
The Cardioprotective Effects of Empagliflozin with and Without ACE Inhibition in Chemotherapy-Induced CardiotoxicityTim Rozovsky, Adrian Siapno, David Y C Cheung, et al.
Blood Advances|July 12, 2018
Analysis of carfilzomib cardiovascular safety profile across relapsed and/or refractory multiple myeloma clinical trialsAjai Chari, A Keith Stewart, Stuart D Russell, et al.
Structural Heart : the Journal of the Heart Team|July 31, 2023
Cardiac Masses Discovered by Echocardiogram; What to Do Next?Reto Kurmann, Edward El-Am, Ali Ahmad, et al.
The Oncologist|May 31, 2022
Cardiotoxicity from Capecitabine Chemotherapy: Prospective Study of Incidence at Rest and During Physical ExerciseChiara Lestuzzi, Davide Stolfo, Antonino De Paoli, et al.
European Journal of Preventive Cardiology|November 9, 2023
Artificial intelligence electrocardiogram as a novel screening tool to detect a newly abnormal left ventricular ejection fraction after anthracycline-based cancer therapyJohanna E J Jacobs, Grace Greason, Kathryn E Mangold, et al.
Circulation. Cardiovascular Quality and Outcomes|February 29, 2020
Utilization of Cardiac Surveillance Tests in Survivors of Breast Cancer and Lymphoma After Anthracycline-Based ChemotherapyKathryn J Ruddy, Lindsey R Sangaralingham, Holly Van Houten, et al.
Cardiovascular Research|January 25, 2024
Ecto-CD38-NADase inhibition modulates cardiac metabolism and protects mice against doxorubicin-induced cardiotoxicityThais R Peclat, Guillermo Agorrody, Laura Colman, et al.
Pageof 27

Showing results (201-210 of 269) with videos related to

Sort By:
Pageof 27
The Oncologist|August 10, 2022
Factors Associated With Physical Activity Levels in Patients With Breast CancerPaulina S Marell, Robert A Vierkant, Janet E Olson, et al.
International Journal of Cardiology|June 10, 2016
Relation between fractional flow reserve value of coronary lesions with deferred revascularization and cardiovascular outcomes in non-diabetic and diabetic patientsZhi Liu, Yasushi Matsuzawa, Joerg Herrmann, et al.
Cell Metabolism|June 17, 2025
Itaconate promotes inflammatory responses in tissue-resident alveolar macrophages and exacerbates acute lung injuryMengtian Shan, Song Zhang, Zhibing Luo, et al.
Biomedicines|May 4, 2026
The Cardioprotective Effects of Empagliflozin with and Without ACE Inhibition in Chemotherapy-Induced CardiotoxicityTim Rozovsky, Adrian Siapno, David Y C Cheung, et al.
Blood Advances|July 12, 2018
Analysis of carfilzomib cardiovascular safety profile across relapsed and/or refractory multiple myeloma clinical trialsAjai Chari, A Keith Stewart, Stuart D Russell, et al.
Structural Heart : the Journal of the Heart Team|July 31, 2023
Cardiac Masses Discovered by Echocardiogram; What to Do Next?Reto Kurmann, Edward El-Am, Ali Ahmad, et al.
The Oncologist|May 31, 2022
Cardiotoxicity from Capecitabine Chemotherapy: Prospective Study of Incidence at Rest and During Physical ExerciseChiara Lestuzzi, Davide Stolfo, Antonino De Paoli, et al.
European Journal of Preventive Cardiology|November 9, 2023
Artificial intelligence electrocardiogram as a novel screening tool to detect a newly abnormal left ventricular ejection fraction after anthracycline-based cancer therapyJohanna E J Jacobs, Grace Greason, Kathryn E Mangold, et al.
Circulation. Cardiovascular Quality and Outcomes|February 29, 2020
Utilization of Cardiac Surveillance Tests in Survivors of Breast Cancer and Lymphoma After Anthracycline-Based ChemotherapyKathryn J Ruddy, Lindsey R Sangaralingham, Holly Van Houten, et al.
Cardiovascular Research|January 25, 2024
Ecto-CD38-NADase inhibition modulates cardiac metabolism and protects mice against doxorubicin-induced cardiotoxicityThais R Peclat, Guillermo Agorrody, Laura Colman, et al.
Pageof 27